What 50/50 Can Teach Us About Soft Tissue Sarcoma

On screen

50/50 (2011) follows Adam, a young man in his twenties who is diagnosed with a rare spinal tumor — a soft tissue sarcoma (a schwannoma / neurofibrosarcoma of the spine). Inspired by its screenwriter's own experience, the film balances the fear of a serious diagnosis with humor and friendship. The rarity of Adam's cancer is central to the story, and it makes soft tissue sarcoma a useful thing to explain plainly.

The reality

According to the National Cancer Institute, soft tissue sarcoma is a broad term for cancers that start in soft tissues — muscle, tendons, fat, lymph and blood vessels, and nerves. Because these tissues exist throughout the body, soft tissue sarcomas can develop almost anywhere, though NCI notes they are found mostly in the arms, legs, chest, and abdomen.

"Soft tissue sarcoma" is really a family of cancers rather than a single disease. NCI lists a number of different types under this umbrella, and each can behave differently and be treated differently. A tumor arising from the nerve-related soft tissue near the spine, like Adam's, falls within this broad category of cancers that begin in the body's connective and supporting tissues.

Because these are cancers of the tissues that hold the body together and run through it, their location and type shape how a care team approaches treatment. NCI organizes its soft tissue sarcoma information around the different types and how they are treated, along with research and clinical trials.

What the story gets right — and what to remember

The film's framing is accurate in spirit: soft tissue sarcomas are relatively uncommon, and they can arise in unexpected places because soft tissue is everywhere. Adam's shock at a diagnosis he'd never heard of mirrors how many people first encounter the word "sarcoma."

What a movie can't show is how much these cancers vary from person to person. The many types differ, and any individual's treatment depends on the specifics of their tumor. Nothing here is medical advice, and Adam's experience should not be read as a guide to anyone's diagnosis — those conversations belong with a person and their healthcare team.

Awareness, screening & prevention

It's important to be straightforward about what NCI does and doesn't offer here. For soft tissue sarcoma, NCI states it does not have PDQ evidence-based information about prevention, and it does not have PDQ evidence-based information about screening. So rather than inventing prevention or screening steps, the honest, NCI-supported takeaway is understanding: knowing that soft tissue sarcoma is a broad group of cancers that begin in muscle, fat, nerves, blood and lymph vessels, and other soft tissues, and that they can appear anywhere in the body. Awareness of the category itself is the realistic goal.

Turning a story into something useful

50/50 introduced a wide audience to a cancer many had never heard named. Learning what soft tissue sarcoma actually is — a family of cancers of the body's soft, connective tissues — turns an affecting film into real understanding. Sharing that knowledge and supporting free cancer education helps keep clear, accurate information within reach for people navigating a rare diagnosis.

Questions to ask a healthcare team

• What does it mean that soft tissue sarcoma is a group of different cancers?
• Which soft tissues can a sarcoma start in, and how does location affect care?
• What kinds of treatment are used for soft tissue sarcomas?
• Where can I find reliable, plain-language information about this diagnosis?